AST SpaceMobile's Analyst Targets Range From $42 to $115 — Now a Securities Lawsuit Is in the Mix September 21, 2026

  [NEXT WEEK Featured Pretiming Report]

📌 Next Week's Featured Ticker: ASTS
Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

AST SpaceMobile shares have fallen more than 35% over the past 90 days, sliding from a May all-time high of $133.86 to the high-$50s to mid-$60s range where the stock trades now. That's a dramatic round-trip for a company that just launched its largest satellites yet and reaffirmed full-year revenue guidance. Before SPR's technical coverage on ASTS updates next week, here's the fundamental picture: what's actually happening with the satellite build-out, where analysts have landed after a messy earnings quarter, and the fresh legal overhang that's now part of the story.

The News Behind the Move

Picture a company trying to build a cellular network in space, launching satellites three times larger than anything it's flown before, while simultaneously fighting a battle on two fronts — one against the physics of scaling a constellation, and another against a much better-funded rival that just went public. That's where AST SpaceMobile sits heading into next week. On August 5, the company successfully launched BlueBird satellites 11, 12, and 13 aboard a Falcon 9 rocket — the largest communications arrays ever deployed in low Earth orbit, more than three times the size of its original Block 1 units, designed to support peak data rates approaching 200 Mbps directly to ordinary smartphones. Production is now advancing through satellite 42, and the company has expanded its partnership network across Europe, with Vodafone, Orange, Telefónica, Deutsche Telekom, and Vodafone Ukraine now running network integration testing across eight countries.

The second-quarter earnings print that landed in early August was more mixed. Revenue came in at $31.5 million, below the $35.2 million analysts expected, and adjusted losses of $0.77 per share missed a projected $0.26 loss by a wide margin. But look past the headline miss and the sequential trend tells a different story — revenue more than doubled from $15.8 million in the first quarter, and management reaffirmed its full-year guidance of $150 million to $200 million, weighted heavily toward the fourth quarter as the network scales toward commercial service. The company also closed a $1.15 billion convertible notes offering in July, pushing pro forma liquidity above $3.7 billion against a $1.3 billion revenue backlog — capital it's burning quickly, with quarterly capital expenditures jumping from $257 million in the first quarter to $610 million in the second as satellite production accelerates.

What Wall Street Analysts Are Saying

The range of opinion on this stock is about as wide as it gets in large-cap coverage, and it's widened further since earnings.

• Cantor Fitzgerald — reiterated Overweight, raised its target to $90 following the Q2 print
• Berenberg — initiated coverage with a Buy rating and $92 target, citing falling launch costs across the space industry as a long-term tailwind
• Street consensus — 14 analysts covering the stock, with an average target near $80 and a blended figure that's actually been nudged higher in recent weeks (from roughly $71.51 to $78.48) even as individual targets get trimmed, reflecting refreshed models built around government demand and the reaffirmed guidance
• Full range — estimates span from a low of $42.50 to highs between $108 and $115 depending on the data source, implying upside north of 30% from current levels at the midpoint

That's an unusually wide spread even for a pre-commercial-scale growth story, and it says something important: analysts broadly agree the long-term opportunity is real, but they're nowhere close to agreeing on how much execution risk to price in along the way.

Is ASTS Overvalued or Undervalued?

Traditional valuation metrics don't do much work here — a company generating $31.5 million in quarterly revenue against losses of roughly $0.77 per share isn't one you value on a P/E multiple. The more useful lens is the gap between today's business and the one management is promising: $150–200 million in revenue this year, weighted almost entirely toward the back half, against a stated ambition of $1 billion in the company's first full year of commercial service. That's the entire investment case in one sentence — the stock is priced on a 2027-and-beyond narrative, not on 2026's actual numbers.

The balance sheet gives that narrative some runway. With over $3.7 billion in pro forma liquidity and a $1.3 billion contracted backlog, AST SpaceMobile isn't at near-term risk of running out of capital to finish the build-out. But the trajectory of spending — capex roughly doubling quarter-over-quarter — means the company will likely keep returning to capital markets, and each of those raises is a reminder of how much distance remains between today's revenue and the guidance analysts are underwriting their targets with.

The Risk Variables Investors Should Watch

Three threads worth following past next week:

A securities class action just entered the picture. In mid-September, shareholders filed suit alleging the company's disclosures around competitive pressure from Starlink and its pattern of capital raises misled investors — with at least one law firm publicly investigating additional claims on behalf of long-term shareholders. Litigation risk doesn't change the satellite math, but it adds a layer of overhang that wasn't part of the story even a month ago.

The competitive landscape just got a lot more well-capitalized. SpaceX's own direct-to-cell ambitions come from a company that recently completed its IPO at a valuation between $1.75 trillion and $2 trillion — a scale of resources that dwarfs AST SpaceMobile's balance sheet, even with billions in liquidity on hand. How the two companies' direct-to-device technologies compare on coverage and speed as both scale is likely to be a recurring theme in coverage from here.

Capital raises are a recurring, not one-time, event. Between the July convertible notes offering and a separate lawsuit over roughly $15 million in disputed finder's fees tied to earlier capital-raising activity, the pattern of returning to markets to fund an aggressive satellite production schedule is well-established — and analysts' own commentary suggests they expect it to continue.

If the Story Shifts From Here

Suppose the European carrier integration testing translates into signed commercial agreements before year-end, or fourth-quarter revenue comes in at the high end of the $150–200 million guidance range — that's the scenario where the $90–92 targets from Cantor Fitzgerald and Berenberg start to look conservative rather than aggressive. Now suppose instead the securities litigation expands, or satellite production hits delays the way earlier BlueBird launches sometimes have — that's the scenario where the $42.50 low-end target, and the stock's already-sharp pullback from its May highs, prove to be the more accurate read on how much execution risk this story still carries. Where the stock settles between those outcomes is exactly what next week's technical coverage is built to capture.

Conclusion

One-line takeaway: AST SpaceMobile's satellite build-out and European partnerships are genuinely advancing, but a Q2 miss, an accelerating cash burn, and a fresh securities lawsuit have widened the gap between the bull and bear case to nearly $75 a share — and next week's technical read will show which side the market is currently leaning toward.

Next week, SPR's Pretiming Report will bring the technical read on ASTS — zone positioning, directional bias, and the trading framework built around it. Watch for it at pretiming.report.

TQQQ Sank Toward $70 as the Fed Turns Hawkish — Next Week's FOMC Meeting Is the Wildcard September 8, 2026

 [NEXT WEEK Featured Pretiming Report]

📌 Next Week's Featured Ticker: TQQQ
Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

TQQQ traded around $72.37 as of Friday's close, with its net asset value down nearly 8% over the past month — a sharper decline than the Nasdaq-100 itself has posted, which is exactly what a 3x leveraged fund is built to do in both directions. Before SPR's technical coverage on TQQQ updates next week, here's the fundamental picture worth understanding: what's driving the underlying index lower, how the fund's leverage mechanics amplify that move, and why next week's Federal Reserve meeting is the single biggest variable on the calendar.

The News Behind the Move

Picture the AI rally that's powered the Nasdaq-100 for the better part of two years suddenly running into a wall named Kevin Warsh. In his debut keynote as Federal Reserve chair at the Jackson Hole Economic Policy Symposium on August 28, Warsh struck a notably hawkish tone, describing recent inflation readings as "concerning" and stating the Fed needs confidence that inflation is moving toward its target "clearly and at sufficient speed." Markets read that as a signal the central bank isn't done fighting inflation — fed funds futures pushed the odds of a September rate hike from roughly 40% before the speech to over 60% after it, and the 10-year Treasury yield climbed toward 4.66% in response.

That's a difficult backdrop for a fund built entirely on mega-cap technology names that had already run hard. Layer on top of it renewed skepticism about the sheer scale of AI infrastructure spending — chipmakers and AI-exposed names across the Nasdaq-100 have seen bouts of sharp selling in recent weeks as investors question whether current capital expenditure levels are matched by near-term returns. The result: TQQQ's net asset value has fallen roughly 7.95% over the past month, even as the fund still shows a positive 3-month net inflow of about $2.28 billion — a sign that some traders are treating the dip as a buying opportunity even as others head for the exits, reflected in roughly $3.75 billion of net outflows over the trailing year.

What the Fund Actually Holds

TQQQ doesn't have its own earnings or its own balance sheet — its fortunes are entirely a function of the Nasdaq-100 Index, magnified three times over on a daily basis. That makes concentration the first thing worth understanding. As of late August, the underlying Invesco QQQ Trust's top five holdings — NVIDIA at roughly 8.73%, Apple at 7.31%, Alphabet at 6.06%, Microsoft at 5.94%, and Micron Technology at 4.61% — made up nearly a third of the entire index on their own, with the top 10 holdings accounting for close to 46% of total weight. When a handful of mega-cap technology and semiconductor names move together, as they have during recent selloffs, TQQQ doesn't just feel it — it feels it three times over.

The index itself isn't static, either. SpaceX joined the Nasdaq-100 in early July, one of several recent additions that continue to tilt the benchmark further toward high-growth, high-valuation names rather than diversifying away from the mega-cap technology concentration that's defined the index for years.

The Leverage Structure — Why This Isn't a Buy-and-Hold Position

Here's the mechanic that matters more for TQQQ than for almost any conventional stock: the fund resets its 3x exposure every single trading day. That daily reset means TQQQ's return over any period longer than a single day is not simply three times the Nasdaq-100's return over that same period — it's a compounded product of daily returns, and in a choppy or declining market, that compounding works against holders. A market that moves sideways with volatility can cause TQQQ to lose value even if the underlying index is roughly flat, purely from the mechanics of daily rebalancing. ProShares itself is explicit about this: the fund "should be avoided by those with a low risk tolerance or a buy-and-hold strategy," and is intended for investors with a bullish short-term outlook, not a multi-year holding.

The current environment makes that mechanic especially relevant. A market swinging on every Fed headline, CPI print, and AI-spending data point is precisely the kind of choppy tape where daily-reset decay tends to bite hardest — a dynamic worth understanding well before looking at where the stock is trading on any given day.

The Risk Variables Investors Should Watch

Three threads worth following into next week and beyond:

The FOMC decision lands squarely in next week's window. The Federal Reserve's meeting concludes September 16, and with rate-hike odds having roughly doubled since Warsh's Jackson Hole remarks, this is the single clearest binary catalyst on the calendar. A hike, or even hawkish guidance without a hike, would likely pressure the same high-multiple technology names that make up the bulk of the Nasdaq-100 — and TQQQ would feel that three times over.

Concentration risk cuts both ways. The same mega-cap dominance that powered TQQQ's rally over the past two years means a handful of disappointing earnings reports, capex guidance changes, or regulatory headlines from just a few companies can move the entire fund sharply — there's very little diversification cushioning a stumble in any single name near the top of the index.

Elevated valuations leave less room for error. With inflation concerns pushing yields higher and AI-spending scrutiny intensifying, a market that had priced in continued perfection has less cushion to absorb disappointing data than it did earlier in the rally.

If the Story Shifts Before the FOMC Decision

Suppose the August CPI and PPI data due before the meeting come in soft, giving the Fed room to hold rates steady rather than hike — that's the scenario some strategists are already positioning for, and it would likely relieve pressure on the exact high-multiple names TQQQ is leveraged against. Now suppose inflation data instead confirms Warsh's concerns and the Fed does raise rates on September 16 — that's the scenario where the daily-reset decay this report just walked through would compound most painfully, especially if it comes alongside continued AI-valuation skepticism. Which of those two paths plays out — and how sharply the fund reacts to whichever one does — is exactly what next week's technical coverage is built to capture.

Conclusion

One-line takeaway: TQQQ's fate over the next two weeks is almost entirely a function of two things outside any single company's control — the September 16 FOMC decision and whether mega-cap tech concentration in the Nasdaq-100 becomes a liability or a tailwind — and the fund's daily-reset leverage mechanics mean the size of the move matters just as much as its direction.

Next week, SPR's Pretiming Report will bring the technical read on TQQQ — zone positioning, directional bias, and the trading framework built around it. Watch for it at pretiming.report.

Robinhood's Prediction Markets Now Outearn Stock and Crypto Combined — Analysts Are Chasing $150 September 8, 2026

 [NEXT WEEK Featured Pretiming Report]

📌 Next Week's Featured Ticker: HOOD
Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

Robinhood closed Monday at $122.00, up sharply from a 52-week low near $63.52 set back in March. What's driving Wall Street's continued enthusiasm isn't the crypto trading desk that made the company famous during the meme-stock era — it's a product fewer than 2 million of Robinhood's 28 million customers have even touched. Before SPR's technical coverage on HOOD updates next week, here's the fundamental picture: what's actually driving the business, where analysts have set their targets, and the regulatory question mark now hanging over Robinhood's newest growth engine.

The News Behind the Move

Think about a brokerage built on stock and options trading suddenly discovering its fastest-growing business is neither of those things. That's Robinhood's second quarter of 2026, reported July 29: total net revenue rose 32% year-over-year to $1.31 billion, and net income climbed 48% to $573 million. But the number that caught Wall Street's attention wasn't the top line — it was the mix underneath it. Prediction markets, where customers trade contracts tied to real-world outcomes, generated $156 million in quarterly revenue, more than the $129 million from equities trading and the $100 million from crypto combined. Fewer than 2 million customers have used the product at all.

The rest of the quarter backed up the story. Average revenue per user climbed 24% year-over-year to $187, even as the funded account base grew a more modest 7% to 28.4 million. Gold subscribers hit a record 4.8 million, net deposits reached $21.7 billion for the quarter, and the company now counts 13 distinct business lines each generating more than $100 million in annualized revenue — retirement accounts, banking, advisory, and its Rothera derivatives exchange among them. Management has flagged the September 29–30 HOOD Summit as the next milestone where more of that strategy gets laid out publicly, and the company's next earnings report is expected around November 3.

What Wall Street Analysts Are Saying

The upgrades have been landing in twos and threes over the past few weeks, and almost all of them point the same direction.

• Bernstein — reiterated its $160 target, the highest in current coverage
• Morgan Stanley (Michael Cyprys) — upgraded to Overweight from Equal-weight on September 1, raising the target to $150 from $124, and lifting 2026–2028 earnings estimates by 12% to 15% along the way
• Goldman Sachs — raised its target to $123 from $118, maintaining an Overweight/Buy stance
• Street average — FactSet data shows a consensus target near $125–126, with TipRanks tallying 16 Buy ratings against 2 Holds among 18 analysts, and LSEG data showing 22 of 28 covering analysts at buy or strong buy

That leaves a forecast range running from roughly $100 on the low end to $160 on the high end — a spread that, notably, sits almost entirely above where the stock trades today, which is a different picture than the wider, more evenly split ranges seen on some of the earlier names in this series.

Is HOOD Overvalued or Undervalued?

This is where the prediction-markets story runs into a real tension. Robinhood trades at a trailing P/E in the 45–61 range depending on the data source and timing, a forward P/E above 50, and a price-to-sales ratio near 19 times trailing revenue — multiples that price in a great deal of continued growth, not a mature, slow-growing brokerage. Return on equity of roughly 23.6% and net margins above 40% give the bull case something real to point to, but this is unambiguously a stock priced for the future it's promising rather than the business it already has.

Morgan Stanley's own target math is a useful window into how the bulls are thinking: the firm's $150 figure applies a 25-times multiple to probability-weighted 2031 earnings — a genuinely long time horizon, and one that assumes prediction markets, Rothera, and the rest of the 13 business lines keep compounding roughly as they have. That's a defensible bet given the trendline, but it's also exactly the kind of assumption that leaves little room for a stumble along the way.

The Risk Variables Investors Should Watch

Three threads worth following past next week:

The regulatory ground under prediction markets just shifted. The Ninth Circuit ruled that sports event contracts offered by Robinhood, Kalshi, and Crypto.com are not swaps under the Commodity Exchange Act — on the surface a legal win, but one that opens the door for individual states like Nevada to apply their own gaming laws to those same contracts. A product generating more revenue than Robinhood's entire crypto and equities businesses combined is now navigating a patchwork of potential state-level rules rather than a single federal framework.

Tokenization is now a public fight, not just a regulatory filing. Robinhood CEO Vlad Tenev has been publicly defending the company's tokenized-stock ambitions after AMC's CEO Adam Aron challenged their legality, and the SEC's tailored rules for crypto contracts and tokenized securities are still pending. How that framework lands will matter for whether Robinhood can bring products it already offers overseas to U.S. customers.

Crypto volumes are actually falling even as the stock rallies. Morgan Stanley's own upgrade explicitly cut its crypto revenue forecasts for Robinhood while raising overall earnings estimates — a reminder that the bull case here has quietly rotated away from the business Robinhood is best known for and toward newer, less-tested revenue lines.

If the Story Shifts From Here

Suppose the HOOD Summit later this month lays out a credible roadmap for scaling prediction markets internationally, or Nevada and other states opt not to aggressively apply gaming law to event contracts — that's the scenario where Bernstein's $160 and Morgan Stanley's $150 targets start to look achievable rather than aspirational. Now suppose instead state regulators move quickly to restrict sports-related contracts, or the tokenization dispute drags into prolonged SEC uncertainty — that's the scenario where a stock already trading near 50 times forward earnings has the most room to give back. Which of those paths plays out first is exactly what next week's technical coverage is built to capture.

Conclusion

One-line takeaway: Robinhood's growth engine has genuinely shifted toward prediction markets and platform monetization rather than crypto, and Wall Street has raised targets to match — but the same regulatory ambiguity that let this business grow this fast is now the biggest variable in whether it keeps compounding.

Next week, SPR's Pretiming Report will bring the technical read on HOOD — zone positioning, directional bias, and the trading framework built around it. Watch for it at pretiming.report.

SOXL Preview: What to Watch in the 3x Semiconductor Bull ETF Ahead of Next Week’s Spotlight August 31, 2026

 [NEXT WEEK Featured Pretiming Report]

📌 Next Week's Featured Ticker: SOXL
Each week, SPR features one ticker for in-depth coverage.
The Weekly Pretiming Report is updated both this week and
next week, while the Daily Pretiming Report is updated
throughout next week's trading sessions. All reports are
published at pretiming.report.

If you’ve been tracking the semiconductor space this summer, you’ve probably felt the whiplash. One week the AI narrative feels unstoppable; the next, bond yields spike or a geopolitical headline lands and the whole group takes a sharp breath. That volatility is precisely why the Direxion Daily Semiconductor Bull 3X Shares (SOXL) keeps drawing attention—and why it is SPR’s featured ticker for next week’s Pretiming Report update. Before the technical analysis lands, it helps to step back and understand the underlying business drivers, the Street’s mixed signals, the near-term catalysts, and the structural risks that come with triple daily leverage.

Recent News and the Backdrop for Price Swings

SOXL does not own a single company in isolation. It seeks 300% of the daily performance of an index of the roughly 30 largest U.S.-listed semiconductor names. That means every piece of news that moves Nvidia, Micron, AMD, Broadcom, or the equipment makers gets amplified.

In late August the fund saw both sharp inflows and sudden drops. On one recent session it fell more than 9% as reports circulated that the administration might allow Apple to source certain memory chips from Chinese suppliers ChangXin Memory Technologies and Yangtze Memory. The concern hit Micron and other memory names hardest—Micron has been among SOXL’s larger equity exposures. At the same time, Korean retail investors poured hundreds of millions into SOXL in a single week, treating the leveraged product as a high-conviction way to ride the AI semiconductor theme. Bank of America added another layer of caution, flagging the possibility of further near-term pressure on the broader semiconductor index even while maintaining a constructive longer-term view on demand.

Bond yields have also played a recurring role. When the 30-year Treasury yield pushed higher, high-multiple growth names—including many chipmakers—faced rotation pressure. The result for SOXL has been the kind of daily percentage moves that only leveraged products can deliver: double-digit swings in either direction within a single session.

How Wall Street Is Viewing the Semiconductor Group

SOXL itself does not carry traditional analyst price targets the way an individual stock does. Instead, the consensus view is best read through the underlying holdings and the non-leveraged semiconductor ETFs that track the same universe.

Across the major names that dominate the index—Nvidia, Micron, AMD, Broadcom, Applied Materials, Lam Research, and others—the aggregate rating remains skewed toward Buy or Strong Buy. Bank of America’s semiconductor team has been particularly vocal: they see solid underlying demand but warn of near-term headwinds from rates, positioning, and geopolitics that could produce another roughly 10% pullback in the broader semiconductor index. At the same time they have highlighted several of the larger holdings as “enhanced buying opportunities” on weakness, citing a still-attractive forward multiple relative to expected earnings growth through 2028.

The spread of opinions is real. Some desks emphasize the durability of AI infrastructure spending and the multi-year ramp in high-bandwidth memory and advanced packaging. Others focus on valuation stretch after the powerful run earlier in 2026, the risk of circular financing concerns, and the possibility that CapEx growth could moderate. That divergence itself is useful information: the market is not speaking with one voice, which often precedes periods of elevated volatility—the exact environment in which a 3x product can move farthest, both up and down.

Upcoming Earnings and Consensus Checkpoints

SOXL does not report earnings of its own, but its daily performance is heavily influenced by the reporting calendar of its largest constituents. Broadcom is scheduled to report fiscal third-quarter results on September 2 after the close—right at the start of the week the Pretiming Report will cover. Consensus has been looking for substantial year-over-year growth driven by AI-related networking and custom silicon. Nvidia reported in late August; Micron’s next major update is later in September. Equipment names such as Applied Materials and Lam Research have already provided recent updates that reinforced the CapEx narrative.

The pattern so far in 2026 has been that many of these companies have delivered strong numbers and guidance, yet the subsequent price reaction has sometimes been muted or even negative when the broader tape is risk-off. That gap between fundamental delivery and market response is one of the variables investors tend to watch most closely when a leveraged product is involved.

What Valuation Is Signaling

Traditional valuation metrics apply only indirectly to SOXL. The fund’s expense ratio sits in the 0.75–0.91% range, and its assets under management have fluctuated in the high teens to low twenties of billions of dollars amid large creation and redemption activity. The more relevant valuation conversation lives at the index level. Many of the largest semiconductor names trade at elevated multiples on trailing earnings, yet those multiples look more moderate when measured against multi-year expected earnings growth rates that still run well above the broader market. Bank of America has described the sector’s forward multiple as relatively inexpensive against a projected 70% earnings CAGR through 2028. Whether that growth materializes at the expected pace remains the open question.

For a leveraged ETF the practical implication is straightforward: valuation compression or expansion in the underlying index is magnified roughly threefold on a daily basis, and compounding effects mean that multi-day moves can diverge significantly from a simple 3x calculation.

Key Variables and Risks Investors Should Keep in View

Several factors stand out as particularly relevant in the near term:

• AI CapEx sustainability and hyperscaler spending. The long-term demand case remains intact according to most major banks, but any sign of digestion or pushback on data-center projects can hit the group hard.
• Geopolitics and supply-chain policy. Memory-chip sourcing decisions, potential new tariffs, and export controls continue to create headline risk, especially for Micron and related names.
• Interest rates and rotation. Higher longer-term yields have repeatedly pressured high-duration semiconductor stocks.
• Leverage mechanics themselves. Daily reset means SOXL is designed for short-term directional exposure. Holding through multi-day volatility can produce returns that differ markedly from three times the index move, both positively and negatively. Volatility decay is a structural feature, not a temporary one.
• Concentration. Even with roughly 30 names in the index, a handful of megacap and memory companies exert outsized influence.

If the upcoming Broadcom report and any accompanying commentary on AI networking demand come in stronger than expected, the underlying index could catch a bid and SOXL would be expected to amplify that move. If the report is solid but the market focuses on any cautious language about longer-term growth or margins, or if macro headlines dominate, the opposite reaction is equally plausible. In either case the magnitude of the move is likely to be larger than what a non-leveraged semiconductor ETF would experience.

One-line takeaway

SOXL compresses the entire semiconductor debate—AI demand strength, geopolitical friction, rate sensitivity, and valuation—into a single high-octane daily instrument; understanding those fundamental currents is the best preparation before the next technical update arrives.

Next week’s SPR Pretiming Report will provide the updated technical framework for SOXL. Until then, the story remains one of powerful underlying demand colliding with elevated near-term uncertainty—exactly the kind of setup that keeps this ETF in the spotlight.

AXTI Beat Earnings by Nearly 3x, Then Gave Back Half Its Rally — What the Fundamentals Still Say August 24, 2026

AXTI Stock Could Be the Next AI Winner — But One China Risk Could Change Everything

[NEXT WEEK Featured Pretiming Report]

📌 Next Week's Featured Ticker: AXTI
Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

Six weeks ago, AXT was a quiet, niche materials supplier trading in the high-$30s. Then a blowout earnings print sent it as high as $96, before the stock gave back a meaningful chunk of that move and now trades in the high-$60s to low-$70s. Before SPR's technical coverage on AXTI updates next week, here's the fundamental case underneath the volatility: what actually drove the surge, what Wall Street thinks it's worth now, and the export-permit risk that's been the company's recurring headache for three years running.

The News Behind the Move

Picture a small semiconductor-materials company that most investors had never heard of, quietly supplying the wafers that go into fiber-optic lasers — and then AI data center demand shows up at its door all at once. That's the AXT story in one image. The company's second-quarter 2026 results, reported in late July, showed revenue of $47.6 million against a Wall Street estimate of $34.1 million, more than doubling from $18.0 million a year earlier. Adjusted earnings per share came in at $0.19 versus a $0.07 consensus, flipping the company from a prior-year loss into solid profitability. The driver was record indium phosphide (InP) revenue of $30.7 million — InP being the material used in the high-speed optical transceivers that move data between AI servers.

Management didn't treat it as a one-off. Guidance for the current quarter calls for EPS of $0.30–$0.32 on roughly $66 million in revenue, and the company has set a target of reaching $140 million in annualized InP production capacity by the end of 2026. Backing that expansion is a long-term supply agreement with Lumentum running through 2031, secured with $87 million in customer deposits — the kind of commitment that suggests this isn't just a spot-market spike. The expansion itself was funded in April, when AXT raised roughly $550 million in a stock offering priced at $64.25 per share specifically earmarked for its Chinese subsidiary Tongmei's InP capacity buildout.

What Wall Street Analysts Are Saying

The Street moved quickly once the numbers came in, and it moved almost entirely in one direction.

• Wedbush — reiterated Outperform, $93 target
• Needham — upgraded to Buy, $90 target
• B. Riley — raised its target to $55 from $52, the most conservative of the group
• Street average (per S&P Global, 5 analysts) — consensus rating of "Buy," average target near $91, with estimates ranging from a low of $55 to a high of $125

That's still meaningfully above where the stock trades today even after its pullback from the mid-$90s — but it's worth noting the range itself: a $70 gap between the most cautious and most optimistic targets on a stock that's already moved this fast is a signal that analysts are still calibrating how durable the AI-driven demand really is.

Is AXTI Overvalued or Undervalued?

This is genuinely a harder call than it looks. On one hand, the company just posted a quarter with 32.2% gross margin and positive free cash flow of about $3.6 million — real, cash-generating profitability, not just a revenue headline. The balance sheet is unusually strong for a company this size: roughly $412 million in cash, a current ratio near 4.8, and minimal long-term debt, largely thanks to the spring capital raise.

On the other hand, a stock that ran from the high-$30s to the mid-$90s in a matter of weeks has, by definition, priced in a great deal of future growth already. Even management's own bullish framing — reaching $140 million in InP capacity by year-end — implies the market is already looking well past this year's results toward 2027 and beyond. Whether that's justified depends heavily on two things: how consistently China's export-permit process behaves, and whether gross margins can climb from the low-30s toward the "40s" management has been targeting as capacity utilization improves.

The Risk Variables Investors Should Watch

Three threads worth following past next week:

Export permits remain the company's oldest and most persistent risk. Every shipment of gallium arsenide, germanium, and indium phosphide substrates out of China requires individual approval from China's Ministry of Commerce — a process AXT has been navigating since 2023. As recently as the fourth quarter of 2025, revenue came in below guidance specifically because fewer permits were issued than expected. The current growth story assumes that process stays smooth; it hasn't always.

The Tongmei IPO overhang is still unresolved. AXT's Chinese subsidiary Tongmei first applied to list on Shanghai's STAR Market back in January 2022, and as of the company's most recent disclosures, that listing remains under regulatory review with no assurance of approval. A resolution either way — approval or a formal withdrawal — would be a structural event for how investors value AXT's stake in its own manufacturing base.

Dilution has already happened once this year and could happen again. The April equity raise added over 8.5 million new shares to fund expansion. A company scaling capacity this fast, even while generating positive free cash flow, tends to keep capital markets as an option on the table rather than off it.

If the Story Shifts From Here

Suppose Tongmei's export permits keep flowing smoothly and the Lumentum ramp accelerates faster than guided — that's the scenario where Wedbush's and Needham's targets start to look conservative rather than aggressive, and gross margins climb toward the "40s" management has flagged. Now suppose instead permit delays resurface the way they did in late 2025, or the Tongmei IPO stalls in a way that unsettles the ownership picture — that's the scenario where B. Riley's more cautious $55 target, and the stock's sharp pullback from its August high, look like the more accurate read on how much of this growth is durable. Where the stock actually settles between those two outcomes is exactly what next week's technical coverage is built to capture.

Conclusion

One-line takeaway: AXTI's earnings turnaround is real and cash-generative, but the stock's round-trip from the high-$30s to $96 and back into the $70s shows the market is still working out how much of this AI-driven demand is durable versus how much was a re-rating that ran ahead of itself.

Next week, SPR's Pretiming Report will bring the technical read on AXTI — zone positioning, directional bias, and the trading framework built around it. Watch for it at pretiming.report.

IonQ's Revenue Grew 287% — So Why Do Analysts Still Disagree by $51 a Share? August 15, 2026

 📌 Next Week's Featured Ticker: IONQ

Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

IonQ just posted the best quarter in its history, beat revenue estimates by roughly 20%, and raised its full-year outlook — and the stock has responded by ripping higher, up sharply from where it sat before earnings. But ask five analysts where it goes from here and you'll get five different answers, ranging from a company barely worth more than it trades for today to one worth more than double. Before SPR's technical coverage on IONQ updates next week, here's the fundamental picture: what actually happened last quarter, how Wall Street is pricing it, and why the valuation debate on this one is far from settled.

The News Behind the Move

Imagine running a company that's roughly quadrupled its revenue in a year while still losing money on every dollar of it — that's the tension sitting at the center of IonQ's story right now. For the second quarter of 2026, the company reported record revenue of $80.1 million, a 287% year-over-year increase that landed about 20% above the midpoint of its own guidance, marking its fifth consecutive quarter of record results. Management didn't just beat the quarter — it raised its full-year 2026 revenue guidance to $280–290 million, comfortably above the roughly $268 million analysts had penciled in.

The government side of the business is quietly becoming a real growth engine. IonQ's Capella space subsidiary won a National Reconnaissance Office contract to supply commercial synthetic-aperture-radar imagery for national-security missions, and separately, DARPA extended IonQ's contract with an additional $28 million to expand production of its Evergreen-05 optical atomic clocks — hardware used in radar, secure communications, and precision navigation. Layered on top of that, IonQ completed its acquisition of SkyWater Technology, a domestic chip manufacturer, in an all-stock deal, a move aimed at giving the company more control over its own hardware production pipeline. The one number that muddies the picture: GAAP net loss for the quarter came in at a startling $1.87 billion, but the bulk of that was a $1.6 billion non-cash, mark-to-market charge tied to the fair value of warrant liabilities — an accounting artifact, not a cash outflow, though it's the kind of headline number that can spook a reader who doesn't dig into the footnotes.

What Wall Street Analysts Are Saying

Read enough of these notes back to back and a pattern shows up: almost nobody is bearish on IonQ's business, but there's real disagreement about what it's worth today.

• Rosenblatt Securities (John McPeake) — reaffirmed Buy, $100 target, the most bullish figure in coverage
• Jefferies — trimmed its target to $75 from $85 even after the beat, still implying substantial upside from current levels
• Cantor Fitzgerald (Troy Jensen) — maintained Overweight, $70 target, modeling a path to roughly 30% share of the quantum hardware, software, and services market by 2035
• Needham (Quinn Bolton) — reiterated Buy, $65 target, highlighting that international customers made up about half of quarterly revenue
• Morgan Stanley — raised its target modestly to $49 from $48.50, but kept an Equal Weight rating
• JPMorgan (Mayur Ramdhani) — reiterated a Neutral stance

That's a spread running from the high $40s to $100 — a gap of roughly $51 between the most cautious and most bullish targets, which tells you the disagreement isn't about whether the business is growing, it's about how much to pay today for revenue that's still years away from turning into durable profit.

Is IONQ Overvalued or Undervalued?

Here's where the numbers get genuinely hard to reconcile. IonQ trades at a trailing price-to-sales ratio of roughly 62 — steep by almost any conventional standard, but actually a meaningful compression from where the multiple sat earlier this year, purely because revenue has been growing faster than the share price. Look at it from a forward-looking angle instead: at a market cap near $18–19 billion, the stock is being valued at somewhere around 50 times the midpoint of this year's own revenue guidance. That's the kind of multiple that only makes sense if triple-digit growth continues well past 2026.

The balance sheet is the counterweight to that valuation anxiety. IonQ is sitting on roughly $2.1 billion in cash against just $54.5 million in debt — a net cash position of about $5.53 per share — with a current ratio above 10, meaning near-term obligations aren't remotely a concern. Set against that, return on equity sits at around -60% and return on invested capital near -26%, a reminder that the company is still burning meaningfully to fund its growth. The Altman Z-Score of 2.37 lands in what's typically called the "grey zone" — not distress territory, but not the safety of an established, cash-generative business either. In short: the company likely isn't going anywhere, but the stock's price still requires investors to believe in a growth story that hasn't finished playing out.

The Risk Variables Investors Should Watch

Three threads worth following past next week:

Dilution is an ongoing, structural risk, not a one-time event. The SkyWater deal was funded largely in stock, and IonQ recently filed a prospectus supplement covering potential further share issuance — shares outstanding have already climbed roughly 50% over the past year, and a company still burning cash at this scale tends to keep leaning on equity markets.

The valuation gap between bulls and skeptics is unusually wide for a stock this closely covered. When Morgan Stanley and Rosenblatt Securities are more than $50 apart on the same ticker with the same quarter in hand, it signals a genuine disagreement about growth durability — not just rounding differences in a spreadsheet.

Competitive and volatility risk stays elevated. IonQ carries a beta above 3, meaning it tends to move roughly three times as much as the broader market in either direction, and short interest sits near 12.6% of the float — a level that can amplify moves in both directions when sentiment shifts.

If the Story Shifts Before the Next Print

Suppose the SkyWater integration starts translating into visible margin improvement, or another marquee government contract lands the way the DARPA and NRO deals did — that's the scenario where the Rosenblatt and Jefferies camps look prescient, and more analysts drift toward the higher end of the range. Now suppose instead that revenue growth decelerates from the 287% pace, or the cash burn accelerates faster than guidance implies — that's the scenario where the Morgan Stanley and JPMorgan caution starts to look like the correct read, and the 50-times-sales multiple becomes harder to defend. Which of those paths the stock actually leans toward — and where buyers and sellers are drawing their lines — is exactly what next week's technical coverage is built to capture.

Conclusion

One-line takeaway: IonQ's quarter was genuinely strong by the numbers, but the wide gap between analyst price targets shows the market still hasn't agreed on how much growth durability is worth paying for at today's valuation.

Next week, SPR's Pretiming Report will bring the technical read on IONQ — zone positioning, directional bias, and the trading framework built around it. Watch for it at pretiming.report.

NVDA at $219: Wall Street's $303 Target Says This AI Giant Isn't Done Yet August 7, 2026

📌 Next Week's Featured Ticker: NVDA Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

Nvidia closed Thursday at $218.99, essentially flat on the session, and yet the average Wall Street price target sitting above it hasn't budged from the low $300s. That's a roughly 38% gap between where the stock trades today and where 61 analysts think it's headed over the next twelve months. Before SPR's technical coverage on NVDA updates next week, here's the fundamental picture worth understanding first: where the analysts stand, what earnings could bring, whether the valuation still makes sense after this year's run, and the China policy questions still hanging over the stock.

The News Behind the Move

Picture a company that spent most of 2025 absorbing one export-control headline after another — a $5.5 billion inventory charge here, a chip redesign there — and is now, in 2026, fielding purchase orders instead of playing defense. That's roughly where Nvidia sits. At the company's GTC conference in March, CEO Jensen Huang confirmed the company had received purchase orders from Chinese customers, including ByteDance, Alibaba, and Tencent, for more than 400,000 H200 units. The H200 access itself came after a policy reversal — the chip had been banned, then the Trump administration announced in December 2025 that Nvidia would be permitted to sell the H200 to Chinese customers, with the formal rule taking effect in mid-January 2026.

But the regulatory story isn't finished. As recently as late May, the U.S. Department of Commerce moved to close a loophole that may have let Nvidia's most advanced Rubin and Blackwell processors reach Chinese firms through overseas subsidiaries. If you've ever watched a negotiation where the terms keep shifting mid-conversation, that's the texture of Nvidia's China exposure right now — real revenue on the table, but conditional, capped, and politically reversible.

What Wall Street Analysts Are Saying

If you lined up the last few months of price-target notes side by side, you'd notice something: nobody on Wall Street is calling for a top. The spread runs wide, but it's a spread between "cautiously bullish" and "aggressively bullish," not between bulls and bears.

• UBS (Timothy Arcuri) — $245 target, framing recent Taiwan export softness as a post-holiday normalization rather than a demand problem
• Mizuho (Vijay Rakesh) — $275 target, citing sustained AI-accelerator and memory tailwinds
• Citi (Atif Malik) and Bernstein (David Dai) — both at $300, maintaining buy ratings
• Wells Fargo (Aaron Rakers) — the most bullish of the group, projecting $315 as AI infrastructure demand holds up against a valuation he considers manageable

Across the full analyst pool, 61 analysts polled by S&P Global carry a consensus rating of "Strong Buy" on the stock with an average price target of $302.83, implying roughly 38% upside from current levels. The distribution itself is telling — 58 of 61 analysts rate the shares buy or strong buy, with a forecast range spanning $180 to $500. Even the low end of that range sits below today's price, and it's the outlier, not the center of gravity.

Earnings on the Horizon

Here's the date to circle: Nvidia is expected to report earnings on August 26, 2026, with a consensus EPS estimate of $2.13 and consensus revenue estimate of $93.61 billion. That's not next week's news, but it's close enough on the calendar that positioning ahead of it is already shaping how analysts talk about the stock — and it's the kind of date that tends to color everything in between.

Consider what's riding on that print. Trailing twelve-month revenue already sits at $253.49 billion with $159.61 billion in profit, a return on equity above 114% and a debt-to-equity ratio of just 0.07 — a balance sheet with very little leverage doing the heavy lifting for growth this large. A beat that reaffirms AI-infrastructure demand would likely draw the still-skeptical analysts closer to the Wells Fargo camp. A miss, or cautious guidance tied to China policy uncertainty, would test how much patience the market still has for a stock priced for continued acceleration.

Is NVDA Overvalued or Undervalued?

This is where the "expensive AI stock" narrative runs into some friction with the numbers. Nvidia's forward P/E ratio has actually fallen even as the stock price has risen this year — down to roughly 23, compared to closer to 40 a year earlier — because earnings growth has been outpacing the share-price gains.

Zoom out further and the picture gets more interesting. NVDA's current P/E ratio of roughly 31 sits 44% below its own ten-year historical average of about 54, and the stock's PEG ratio — which weighs the P/E against expected growth — stands at just 0.47, a level growth investors typically associate with a stock still growing faster than its price reflects. One research firm went further, pegging its own fair-value estimate at $371.51 against a price around $200, calling the stock a possible value trap only because the multiple looks unusually cheap relative to the business quality on offer. None of this guarantees the stock is undervalued — a lower multiple can also just mean the market is pricing in more risk around China, competition, or capital-spending cycles. But it complicates any story that treats NVDA as simply "expensive."

The Risk Variables Investors Should Watch

If you're the kind of investor who reads past the headline, three threads are worth following into next week and beyond:

China policy remains genuinely unresolved. The H200 approval came with conditions — Chinese customers cannot receive more than 50% of the total H200 volume sold to American customers, and each shipment requires separate authorization — and the Commerce Department has shown it's still willing to tighten the rules on short notice, as the May subsidiary-loophole closure demonstrated.

Competitive share in China is already eroding. Bernstein has projected Nvidia's market share in China's AI chip sector declining from 66% in 2024 to 54% in 2025, as local competitors grow more aggressively and U.S. sanctions continue to bite. That's a trend line worth watching, not a one-time data point.

Estimate revisions have actually been positive. Consensus EPS estimates for the current year have been raised 7.8% over the past 90 days, which cuts against the idea that Wall Street is growing nervous — if anything, the Street has been getting more comfortable with the numbers, not less.

If the Story Shifts Before August 26

Suppose China grants another batch of licenses in the next two weeks, or a major hyperscaler confirms a large Blackwell or Rubin order — that kind of headline would likely tighten the spread between the UBS and Wells Fargo camps and could pull more analysts toward the higher end of the target range. Now suppose instead that Commerce tightens export terms further, or a peer's earnings disappoint on AI capex — that's the scenario where the stock's low forward multiple gets tested against real demand uncertainty rather than treated as a bargain. Either way, how the stock actually reacts — where it finds support, where sellers step in — is exactly what next week's technical coverage will be built to capture.

Conclusion

One-line takeaway: Nvidia's fundamentals — a falling forward multiple, rising estimates, and a Street-wide $303 average target — are telling a more constructive story than the headline China risk suggests, but the August 26 earnings date and ongoing export-policy shifts are the two variables that will decide which analyst camp turns out to be right.

Next week, SPR's Pretiming Report will bring the technical read on NVDA — zone positioning, directional bias, and the trading framework built around it. Watch for it at pretiming.report.

Tesla Stock Before Earnings: Why Wall Street Can't Agree on TSLA's Next Move

NEXT WEEK Featured Pretiming Report

📌 Next Week's Featured Ticker: TSLA
Each week, SPR features one ticker for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published at pretiming.report.

Tesla just did something that should have sent the stock soaring: it delivered 480,000 vehicles in the second quarter, blowing past Wall Street's forecast of roughly 406,000 by nearly 18%. And yet, on the day that news broke, TSLA had its worst single-day drop in almost a year. That gap — between what the business did and what the stock did — is the whole story right now, and it's exactly the tension investors need to understand before Tesla reports full second-quarter earnings on July 22.

The short version: Tesla's core car business is showing real signs of life again, but the stock's price already reflects a much bigger bet — one on robotaxis, humanoid robots, and a future that hasn't been proven on the income statement yet. Whether that bet gets rewarded or punished this week depends less on the delivery number everyone already knows, and more on a handful of details buried inside the earnings call.

The Paradox: A Record Quarter, A Falling Stock

Picture two investors looking at the exact same headline. One sees "Tesla deliveries jump 25% year-over-year" and thinks the turnaround is finally here. The other sees the stock immediately drop nearly 7.5% on that same news and wonders if something is wrong that the headline isn't telling them.

Both reactions are rational — they're just responding to different layers of the same report. Tesla's delivery beat came in part from steep price cuts and incentives, which means more cars moved, but not necessarily more profit per car. Analysts at Wells Fargo flagged exactly this concern: higher unit volume could be offset by pricing pressure and rising input costs for batteries and raw materials. In other words, Tesla may have bought growth at the expense of margin — and the market, for a moment, cared more about the margin.

That's the kind of surface-versus-structure gap that tends to repeat with Tesla. The headline number looks like a win. The underlying quality of that number is the real question.

Why Wall Street Analysts Are So Divided

If you're looking for a consensus opinion on Tesla right now, you won't find one. That's unusual for a stock this large and this closely covered.

Going into the July 22 earnings report, the spread between the most bullish and most bearish price targets on TSLA is enormous:

• Morgan Stanley: raised its target to $417, Equal Weight
• Jefferies: raised its target to $400, Hold
• Barclays: raised its target to $370, Equal Weight
• Wells Fargo: raised its target to just $130, Sell

The average sits somewhere around $400–$425, but that average hides how little agreement there actually is underneath it. Some analyst panels show a roughly even split between "strong buy," "hold," and "sell" camps, with barely any conviction in either direction. When professional analysts covering the same company, looking at the same numbers, land nearly $300 apart on where the stock should trade, that tells you the disagreement isn't really about the spreadsheet — it's about how much you believe in Tesla's next chapter.

TSLA Q2 2026 deliveries vs. Wall Street estimate — an 18% beat

The Valuation Question: How Much Future Is Already Priced In?

Here's a number worth sitting with: Tesla trades at a price-to-earnings ratio north of 340. For context, that's several multiples above what most established automakers — or even most large-cap tech companies — command. Tesla's net profit margin, meanwhile, sits below 4%.

Think of Tesla's stock price like a rubber band that's already been pulled a long way in advance. The car business alone doesn't stretch that band this far — what stretches it is the market pricing in years of robotaxi expansion, Optimus robot production, and AI-driven margins that don't exist on the balance sheet yet. That's not necessarily wrong; Tesla has surprised skeptics before. But a rubber band pulled that far has less room to stretch further on good news, and a lot more room to snap back on disappointing news.

That asymmetry is exactly why the stock fell on a genuinely strong delivery beat — the good news was already assumed. It's also why the robotaxi expansion into Miami in early July, notably the first launch without a human safety monitor in the vehicle, triggered a sharp rally of over 6% in a single session. The market isn't just grading Tesla on cars anymore. It's grading a story.

Analyst price targets for TSLA span nearly $300 ahead of Q2 earnings

What Actually Matters on July 22

For investors trying to cut through the noise, a handful of specific details in Wednesday's report matter far more than the headline earnings-per-share number:

Automotive gross margin. This is the number that will confirm or deny the Wells Fargo concern — did Tesla's price cuts erode profitability, or did cost discipline offset them?

Capital expenditure guidance. Tesla has already signaled a "very big capital investment phase" tied to autonomy and robotics, with prior guidance around $25 billion for the year. Any further increase raises the stakes on when — or whether — that spending converts into revenue.

Robotaxi and Optimus updates. With Robotaxi service now live in Miami and facing regulatory friction in places like New Jersey, investors will be listening for concrete numbers — rides completed, cities added, safety data — rather than broad ambition.

Options markets are already pricing in a large move. Traders are bracing for a swing of roughly 7–8% in either direction once the numbers hit, which tells you the market itself doesn't have high confidence about which way this breaks.

Building a Strategy Around Uncertainty, Not Against It

If you're holding TSLA or considering a position, the honest starting point is that nobody — not Morgan Stanley, not Wells Fargo, not the options market — has strong conviction about Wednesday's outcome. That uncertainty doesn't have to be paralyzing. It can shape how you size a position and where you draw your lines.

If margins hold up and Robotaxi/Optimus updates sound concrete: this is the scenario where the bulls' thesis — that Tesla is becoming an AI and robotics company, not just a car company — gets a fresh leg of support, and the stock has room to test the upper end of that $400–$425 analyst range.

If margins disappoint but management reaffirms the long-term autonomy story: expect exactly the kind of split reaction seen after the delivery report — a near-term dip on the numbers, followed by attention shifting quickly to the next robotaxi or Optimus milestone.

If both margins and the AI narrative disappoint: this is the scenario the more bearish targets are underwriting, and it's the one where the "rubber band" argument plays out in the other direction.

Whichever scenario unfolds, the lesson from this earnings cycle is the same one long-term investors already know: with Tesla, the headline number is rarely the real story. The real story is in the two or three sentences on the call that tell you whether the future the stock is already pricing in is getting closer — or further away.

---

One-line takeaway: Tesla's delivery beat proved the car business can still surprise to the upside, but the stock's real test on July 22 is whether the AI and robotics story behind its premium valuation holds up under scrutiny.

Want a structured, data-driven read on TSLA's next move — before the headlines catch up? SPR's Pretiming Report tracks Tesla's zone levels, directional bias, and trading discipline points ahead of major catalysts like this one. Explore this week's TSLA Pretiming Report →

This article is for informational and educational purposes only and does not constitute investment advice.

Category: NEXT WEEK Featured Pretiming Report
Target keywords: Tesla stock forecast, TSLA earnings preview, is Tesla stock a buy, Tesla Q2 2026 earnings

Next Week's Featured Pretiming Report: AAOI

Each week, a new ticker is featured for in-depth coverage. The Weekly Pretiming Report is updated both this week and next week, while the Daily Pretiming Report is updated throughout next week's trading sessions. All reports are published on our website (https://pretiming.report).

AAOI has been selected as next week's featured Pretiming Report.

Since the release of the previous AAOI Weekly Pretiming Report, the semiconductor sector has experienced a sharp pullback driven by broad profit-taking and a broader market correction. These developments have led to a significant shift in buying and selling pressure across the sector.

AAOI has been materially affected by this change in market dynamics, experiencing a sharp decline and failing to establish a sustained trend reversal. As selling pressure has continued to outweigh buying demand, the stock has remained under persistent downside pressure.

Given the meaningful deterioration in market structure and the substantial changes in buy-sell flow since the previous report, a follow-up analysis has become increasingly warranted. An updated AAOI Pretiming Report will therefore be released next week, providing a comprehensive reassessment of the stock's trend outlook, risk profile, and potential trading scenarios.